Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Deepika Awasthi

Deepika Awasthi

Lawrence Berkeley National Laboratory, USA

Title: Conversion of methane to bio-products by an engineered microbial platform

Biography

Biography: Deepika Awasthi

Abstract

Methane is an abundantly present, highly potent greenhouse gas that can be obtained from both renewable and non-renewable sources. The United States is the highest global natural gas producer, with a production capacity of 750 billion cubic meters annually. Methane is the major ingredient of natural gas. At the same time, about 300 billion cubic meters of annual methane production occurs biologically from landfills and waste in the United States. Methane is biologically assimilated by organisms categorized as methanotrophs. In the search of alternative carbon source that is not competent to food derived carbon, for manufacturing chemicals to replace petroleum-based products, methane and methanotrophs provide hope. With emerging metabolic engineering practices, recent focus has included engineering and establishing methanotrophs as hosts for bio-based chemical production. Biologically synthesized chemicals are sustainable and are often bio-degradable. Thus, a class of petroleum-derived, non-biodegradable chemicals, called surfactants are looked at for their biological synthesis. Surfactants are agents that reduce the surface tension of a solvent and increase its solubility, hence, surfactants play a crucial and commercially important role in many industries including, pharmaceuticals, agriculture, food, and cosmetics. Rhamnolipids (RLs), are a class of microbial glycolipid- surface active agents that have been classified as the next generation surfactants. RL production requires expensive substrates, additionally, mostly pathogenic bacterial strains are known for high RL production. Use of the plentiful methane as a carbon source for the biological synthesis of RL from non-pathogenic methanotrophic bacteria offers many advantages. This study focuses on engineering methanotroph as a platform for rhamnolipid synthesis. In the present work, efforts are centered to engineer Methylomicrobium alcaliphilum strain 20Z, a GRAS methanotroph, harboring and expressing, heterologous genes essential for RL synthesis (rhlY, rhlZ, rhlA, rhlB) from Pseudomonas aeriuginosa.